SE0202133D0 - Novel compounds - Google Patents
Novel compoundsInfo
- Publication number
- SE0202133D0 SE0202133D0 SE0202133A SE0202133A SE0202133D0 SE 0202133 D0 SE0202133 D0 SE 0202133D0 SE 0202133 A SE0202133 A SE 0202133A SE 0202133 A SE0202133 A SE 0202133A SE 0202133 D0 SE0202133 D0 SE 0202133D0
- Authority
- SE
- Sweden
- Prior art keywords
- novel compounds
- therapy
- processes
- formula
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/20—Spiro-condensed ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Hydrogenated Pyridines (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Priority Applications (29)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0202133A SE0202133D0 (sv) | 2002-07-08 | 2002-07-08 | Novel compounds |
TW092118200A TW200413386A (en) | 2002-07-08 | 2003-07-03 | Novel compounds |
NZ537259A NZ537259A (en) | 2002-07-08 | 2003-07-07 | Novel tricyclic spiropiperidines or spiropyrrolidines |
MXPA05000278A MXPA05000278A (es) | 2002-07-08 | 2003-07-07 | Nuevas espiropiperidinas o espiropirrolidinas triciclicas. |
CNB038191466A CN1326858C (zh) | 2002-07-08 | 2003-07-07 | 三环螺哌啶化合物 |
PL03374877A PL374877A1 (en) | 2002-07-08 | 2003-07-07 | Novel tricyclic spiropiperidines or spiropyrrolidines |
DE60318948T DE60318948T2 (de) | 2002-07-08 | 2003-07-07 | Tricyclische spiropiperidine oder spiropyrrolidine |
CA002492122A CA2492122A1 (en) | 2002-07-08 | 2003-07-07 | Novel tricyclic spiropiperidines or spiropyrrolidines |
PCT/SE2003/001185 WO2004005295A1 (en) | 2002-07-08 | 2003-07-07 | Novel tricyclic spiropiperidines or spiropyrrolidines |
EP03762957A EP1521757B1 (en) | 2002-07-08 | 2003-07-07 | tricyclic spiropiperidines or spiropyrrolidines |
US10/520,699 US7449475B2 (en) | 2002-07-08 | 2003-07-07 | Tricyclic spiropiperidines or spiropyrrolidines |
SI200331163T SI1521757T1 (sl) | 2002-07-08 | 2003-07-07 | Triciklični spiropiperidini ali spiropirolidini |
CNA2006101435561A CN1974574A (zh) | 2002-07-08 | 2003-07-07 | 新的三环螺吡咯烷 |
PT03762957T PT1521757E (pt) | 2002-07-08 | 2003-07-07 | Espiropiperidinas ou espiropirrolidinas tricíclicas |
AU2003243122A AU2003243122B2 (en) | 2002-07-08 | 2003-07-07 | Novel tricyclic spiropiperidines or spiropyrrolidines |
ES03762957T ES2298575T3 (es) | 2002-07-08 | 2003-07-07 | Nuevas espiropiperidinas o espiropirrolidinas triciclicas. |
DK03762957T DK1521757T3 (da) | 2002-07-08 | 2003-07-07 | Tricykliske spiropiperidiner eller spiropyrrolidiner |
AT03762957T ATE385235T1 (de) | 2002-07-08 | 2003-07-07 | Tricyclische spiropiperidine oder spiropyrrolidine |
JP2004519472A JP2005537255A (ja) | 2002-07-08 | 2003-07-07 | 新規三環式スピロピペリジンまたはスピロピロリジン |
BR0312560-2A BR0312560A (pt) | 2002-07-08 | 2003-07-07 | Novas espiropiperidinas ou espiropirrolidinas tricìclicas |
UA20041210166A UA77809C2 (en) | 2002-07-08 | 2003-07-07 | Tricyclic spiropiperidines or spiropyrrolidines, method for their synthesis (variants), use thereof, method for treating inflammations and respiratory diseases, pharmaceutical composition, intermediate, method for producing intermediate |
RU2004137278/04A RU2320664C2 (ru) | 2002-07-08 | 2003-07-07 | Новые трициклические спиропиперидины или спиропирролидины |
AR20030102463A AR040475A1 (es) | 2002-07-08 | 2003-07-08 | Espiropiperidinas o espiropirrolidinas triciclicas |
ZA200500024A ZA200500024B (en) | 2002-07-08 | 2005-01-03 | Novel tricyclic spiropiperidines or spiropyrrolidines. |
IS7662A IS7662A (is) | 2002-07-08 | 2005-01-24 | Ný þríhringlaga spírópíperídín eða spírópýrrólídín |
NO20050635A NO20050635L (no) | 2002-07-08 | 2005-02-04 | Nye tricykliske spiropiperidiner eller spiropyrrolidiner |
HK05106846A HK1074622A1 (en) | 2002-07-08 | 2005-08-09 | Tricyclic spiropiperidines or spiropyrolidines |
CY20081100375T CY1107915T1 (el) | 2002-07-08 | 2008-04-03 | Τρικυκλικες σπιροπιπεριδινες ή σπιροπυρρολιδινες |
US12/265,251 US20090062322A1 (en) | 2002-07-08 | 2008-11-05 | Novel Tricyclic Spiropiperidines or Spiropyrrolidines |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0202133A SE0202133D0 (sv) | 2002-07-08 | 2002-07-08 | Novel compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0202133D0 true SE0202133D0 (sv) | 2002-07-08 |
Family
ID=20288470
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0202133A SE0202133D0 (sv) | 2002-07-08 | 2002-07-08 | Novel compounds |
Country Status (26)
Country | Link |
---|---|
US (2) | US7449475B2 (xx) |
EP (1) | EP1521757B1 (xx) |
JP (1) | JP2005537255A (xx) |
CN (2) | CN1974574A (xx) |
AR (1) | AR040475A1 (xx) |
AT (1) | ATE385235T1 (xx) |
AU (1) | AU2003243122B2 (xx) |
BR (1) | BR0312560A (xx) |
CA (1) | CA2492122A1 (xx) |
CY (1) | CY1107915T1 (xx) |
DE (1) | DE60318948T2 (xx) |
DK (1) | DK1521757T3 (xx) |
ES (1) | ES2298575T3 (xx) |
HK (1) | HK1074622A1 (xx) |
IS (1) | IS7662A (xx) |
MX (1) | MXPA05000278A (xx) |
NO (1) | NO20050635L (xx) |
NZ (1) | NZ537259A (xx) |
PL (1) | PL374877A1 (xx) |
PT (1) | PT1521757E (xx) |
RU (1) | RU2320664C2 (xx) |
SE (1) | SE0202133D0 (xx) |
TW (1) | TW200413386A (xx) |
UA (1) | UA77809C2 (xx) |
WO (1) | WO2004005295A1 (xx) |
ZA (1) | ZA200500024B (xx) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0202133D0 (sv) | 2002-07-08 | 2002-07-08 | Astrazeneca Ab | Novel compounds |
EP1661889A4 (en) | 2003-09-05 | 2009-08-05 | Ono Pharmaceutical Co | ANTAGONIST OF THE CHEMOKINE RECEPTOR AND ITS USE FOR MEDICAL PURPOSES |
US20070021498A1 (en) * | 2004-10-14 | 2007-01-25 | Nafizal Hossain | Novel tricyclic spiroderivatives as modulators of chemokine receptor activity |
SE0302755D0 (sv) * | 2003-10-17 | 2003-10-17 | Astrazeneca Ab | Novel compounds |
SE0302811D0 (sv) * | 2003-10-23 | 2003-10-23 | Astrazeneca Ab | Novel compounds |
SE0303090D0 (sv) * | 2003-11-20 | 2003-11-20 | Astrazeneca Ab | Novel compounds |
SE0303280D0 (sv) * | 2003-12-05 | 2003-12-05 | Astrazeneca Ab | Novel compounds |
SE0303541D0 (sv) * | 2003-12-22 | 2003-12-22 | Astrazeneca Ab | New compounds |
TWI350168B (en) | 2004-05-07 | 2011-10-11 | Incyte Corp | Amido compounds and their use as pharmaceuticals |
NZ551603A (en) | 2004-06-24 | 2010-11-26 | Incyte Corp | N-substituted piperidines and their use as pharmaceuticals |
JP5154406B2 (ja) | 2005-04-13 | 2013-02-27 | アステックス、セラピューティックス、リミテッド | 医薬化合物 |
JP2009507800A (ja) | 2005-09-09 | 2009-02-26 | ユーロ−セルティーク エス.エイ. | 縮合およびスピロ環化合物ならびにその使用 |
JP5315590B2 (ja) * | 2006-02-14 | 2013-10-16 | Jnc株式会社 | 液晶化合物、液晶組成物および液晶表示素子 |
US7754725B2 (en) | 2006-03-01 | 2010-07-13 | Astex Therapeutics Ltd. | Dihydroxyphenyl isoindolymethanones |
AU2007275931B2 (en) * | 2006-07-19 | 2011-06-16 | Astrazeneca Ab | Novel tricyclic spiropiperidine compounds, their synthesis and their uses as modulators of chemokine receptor activity |
WO2008044027A2 (en) | 2006-10-12 | 2008-04-17 | Astex Therapeutics Limited | Pharmaceutical compounds having hsp90 inhibitory or modulating activity |
GB0620259D0 (en) | 2006-10-12 | 2006-11-22 | Astex Therapeutics Ltd | Pharmaceutical compounds |
US8277807B2 (en) | 2006-10-12 | 2012-10-02 | Astex Therapeutics Limited | Pharmaceutical combinations |
WO2008044045A1 (en) | 2006-10-12 | 2008-04-17 | Astex Therapeutics Limited | Pharmaceutical combinations |
WO2008044041A1 (en) | 2006-10-12 | 2008-04-17 | Astex Therapeutics Limited | Pharmaceutical combinations |
WO2008044054A2 (en) | 2006-10-12 | 2008-04-17 | Astex Therapeutics Limited | Hydroxy-substituted benzoic acid amide compounds for use in therapy |
EP2079694B1 (en) | 2006-12-28 | 2017-03-01 | Rigel Pharmaceuticals, Inc. | N-substituted-heterocycloalkyloxybenzamide compounds and methods of use |
EP2120935A4 (en) * | 2007-02-23 | 2011-06-22 | Astrazeneca Ab | NOVEL COMBINATION OF COMPOUNDS FOR THE TREATMENT OF AIRWAY DISEASES, IN PARTICULAR CHRONIC OBSTRUCTIVE BRONCHOPNEUMOPATHY (COPD) AND ASTHMA |
WO2008103125A1 (en) * | 2007-02-23 | 2008-08-28 | Astrazeneca Ab | Novel combination of compounds to be used in the treatment of airway diseases, especially chronic obstructive pulmonary disease (copd) and asthma |
WO2008121066A1 (en) * | 2007-03-30 | 2008-10-09 | Astrazeneca Ab | Novel tricyclic spiropiperidines or spiropyrrolidines and their use as modulators of chemokine receptors |
TW200904423A (en) * | 2007-06-20 | 2009-02-01 | Glaxo Group Ltd | Spiroindolines as modulators of chemokine receptors |
WO2009011653A1 (en) * | 2007-07-17 | 2009-01-22 | Astrazeneca Ab | A process for the preparation of intermediates and their us in the synthesis of spiropiperidine compounds |
WO2009011655A1 (en) * | 2007-07-17 | 2009-01-22 | Astrazeneca Ab | Splropiperidine compounds, a process of their preparation, pharmaceutical compositions containing them, and their use in the treatment of airway diseases, inflammatory diseases, copd or asthma |
JP5292400B2 (ja) * | 2007-07-24 | 2013-09-18 | ブリストル−マイヤーズ スクイブ カンパニー | ケモカイン受容体活性のモジュレーターとしてのピペリジン誘導体 |
JP2010536779A (ja) * | 2007-08-14 | 2010-12-02 | グラクソ グループ リミテッド | ケモカイン受容体のモジュレーターとしてのスピロインデンおよびスピロインダン |
WO2009061881A1 (en) * | 2007-11-07 | 2009-05-14 | Glaxo Group Limited | Spirodihydrobenzofurans as modulators of chemokine receptors |
JP5524083B2 (ja) | 2008-01-30 | 2014-06-18 | セファロン、インク. | ヒスタミン−3(h3)受容体リガンドとしての置換スピロ環状ピペリジン誘導体 |
FR2928150A1 (fr) | 2008-02-29 | 2009-09-04 | Vetoquinol Sa Sa | Nouveaux derives 7-substitues de 3-carboxy-oxadiazino-quinolones, leur preparation et leur application comme anti-bacteriens |
GB0806527D0 (en) | 2008-04-11 | 2008-05-14 | Astex Therapeutics Ltd | Pharmaceutical compounds |
EP2145891A1 (en) | 2008-07-09 | 2010-01-20 | Vetoquinol S.A. | 9-substituted-5-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials |
AR078948A1 (es) * | 2009-11-30 | 2011-12-14 | Lilly Co Eli | Compuestos de espiropiperidina, composicion farmaceutica que lo comprenden y su uso para preparar un medicamento util para tratar la diabetes |
US10633336B2 (en) | 2014-12-19 | 2020-04-28 | The Broad Institute, Inc. | Dopamine D2 receptor ligands |
EP3233799B1 (en) | 2014-12-19 | 2021-05-19 | The Broad Institute, Inc. | Dopamine d2 receptor ligands |
WO2019034697A1 (en) | 2017-08-15 | 2019-02-21 | Inflazome Limited | NOVEL CARBOXAMIDE SULFONAMIDE COMPOUNDS |
Family Cites Families (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4010201A (en) * | 1974-04-12 | 1977-03-01 | The Upjohn Company | Organic compounds |
US4166120A (en) * | 1978-04-14 | 1979-08-28 | American Hoechst Corporation | Analgesic and tranquilizing benzoylpropyl-spiro[dihydrobenzofuran]piperidines and pyrrolidines |
US4166119A (en) | 1978-04-14 | 1979-08-28 | American Hoechst Corporation | Analgesic and tranquilizing spiro[dihydrobenzofuran]piperidines and pyrrolidines |
US4263317A (en) * | 1979-09-06 | 1981-04-21 | Hoechst-Roussel Pharmaceuticals, Inc. | Spiro[cyclohexane-1,1'(3'H)-isobenzofuran]s |
US5366986A (en) | 1988-04-15 | 1994-11-22 | T Cell Sciences, Inc. | Compounds which inhibit complement and/or suppress immune activity |
DE3930262A1 (de) | 1989-09-11 | 1991-03-21 | Thomae Gmbh Dr K | Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
RU2168512C2 (ru) * | 1992-12-11 | 2001-06-10 | Мерк Энд Ко., Инк. | Спиропиперидины, способы их получения (варианты) |
AU693087B2 (en) * | 1993-01-28 | 1998-06-25 | Merck & Co., Inc. | Spiro-substituted azacycles as tachykinin receptor antagonists |
JPH09512016A (ja) * | 1994-04-14 | 1997-12-02 | メルク エンド カンパニー インコーポレーテッド | α1Cアドレナリン受容体拮抗薬 |
US5576321A (en) | 1995-01-17 | 1996-11-19 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
DK0828728T3 (da) | 1995-05-18 | 2003-05-19 | Altana Pharma Ag | Phenyldihydrobenzofuraner |
US5931917A (en) * | 1996-09-26 | 1999-08-03 | Verifone, Inc. | System, method and article of manufacture for a gateway system architecture with system administration information accessible from a browser |
WO1998025605A1 (en) * | 1996-12-13 | 1998-06-18 | Merck & Co., Inc. | Spiro-substituted azacycles as modulators of chemokine receptor activity |
US5962462A (en) * | 1996-12-13 | 1999-10-05 | Merck & Co., Inc. | Spiro-substituted azacycles as modulators of chemokine receptor activity |
WO1998031364A1 (en) * | 1997-01-21 | 1998-07-23 | Merck & Co., Inc. | 3,3-disubstituted piperidines as modulators of chemokine receptor activity |
KR20010040693A (ko) | 1998-02-04 | 2001-05-15 | 나가사까 겐지로 | N-아실 환상 아민유도체 |
US6151675A (en) * | 1998-07-23 | 2000-11-21 | Tumbleweed Software Corporation | Method and apparatus for effecting secure document format conversion |
US6288083B1 (en) | 1998-09-04 | 2001-09-11 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
US6212640B1 (en) * | 1999-03-25 | 2001-04-03 | Sun Microsystems, Inc. | Resources sharing on the internet via the HTTP |
US6226752B1 (en) * | 1999-05-11 | 2001-05-01 | Sun Microsystems, Inc. | Method and apparatus for authenticating users |
EP1224186B1 (en) | 1999-10-27 | 2003-09-24 | Millennium Pharmaceuticals, Inc. | Pyridyl-containing spirocyclic compounds as inhibitors of fibrinogen-dependent platelet aggregation |
AU2001243394A1 (en) | 2000-03-02 | 2001-09-12 | Smith Kline Beecham Corporation | Compounds and methods |
AR028948A1 (es) | 2000-06-20 | 2003-05-28 | Astrazeneca Ab | Compuestos novedosos |
US7017175B2 (en) * | 2001-02-02 | 2006-03-21 | Opentv, Inc. | Digital television application protocol for interactive television |
WO2002102387A1 (en) | 2001-06-18 | 2002-12-27 | H. Lundbeck A/S | Treatment of neuropathic pain |
WO2003037271A2 (en) | 2001-10-30 | 2003-05-08 | Millennium Pharmaceuticals,Inc. | Compounds, pharmaceutical compositions and methods of use therefor |
SE0202133D0 (sv) | 2002-07-08 | 2002-07-08 | Astrazeneca Ab | Novel compounds |
EP1558250A4 (en) | 2002-10-30 | 2006-11-02 | Merck & Co Inc | GAMMA AMINOAMIDE MODULATORS OF THE CHEMOKIN RECEPTOR ACTIVITY |
RU2355679C2 (ru) * | 2002-11-27 | 2009-05-20 | Инсайт Корпорейшн | Производные 3-аминопирролидина в качестве модуляторов рецепторов хемокинов |
WO2004051453A1 (en) * | 2002-12-04 | 2004-06-17 | Entriq Inc. | Multiple content provider user interface |
US7966418B2 (en) * | 2003-02-21 | 2011-06-21 | Axeda Corporation | Establishing a virtual tunnel between two computer programs |
SE0302755D0 (sv) * | 2003-10-17 | 2003-10-17 | Astrazeneca Ab | Novel compounds |
US20070021498A1 (en) * | 2004-10-14 | 2007-01-25 | Nafizal Hossain | Novel tricyclic spiroderivatives as modulators of chemokine receptor activity |
SE0302811D0 (sv) | 2003-10-23 | 2003-10-23 | Astrazeneca Ab | Novel compounds |
SE0303090D0 (sv) | 2003-11-20 | 2003-11-20 | Astrazeneca Ab | Novel compounds |
SE0303280D0 (sv) | 2003-12-05 | 2003-12-05 | Astrazeneca Ab | Novel compounds |
SE0303541D0 (sv) | 2003-12-22 | 2003-12-22 | Astrazeneca Ab | New compounds |
BRPI0509307A (pt) | 2004-03-29 | 2007-09-04 | Pfizer | compostos de alfa aril ou heteroaril metil beta piperidino propanamida como antagonistas do receptor orl1 |
-
2002
- 2002-07-08 SE SE0202133A patent/SE0202133D0/xx unknown
-
2003
- 2003-07-03 TW TW092118200A patent/TW200413386A/zh unknown
- 2003-07-07 EP EP03762957A patent/EP1521757B1/en not_active Expired - Lifetime
- 2003-07-07 WO PCT/SE2003/001185 patent/WO2004005295A1/en active IP Right Grant
- 2003-07-07 RU RU2004137278/04A patent/RU2320664C2/ru not_active IP Right Cessation
- 2003-07-07 AT AT03762957T patent/ATE385235T1/de not_active IP Right Cessation
- 2003-07-07 BR BR0312560-2A patent/BR0312560A/pt not_active IP Right Cessation
- 2003-07-07 ES ES03762957T patent/ES2298575T3/es not_active Expired - Lifetime
- 2003-07-07 MX MXPA05000278A patent/MXPA05000278A/es active IP Right Grant
- 2003-07-07 CA CA002492122A patent/CA2492122A1/en not_active Abandoned
- 2003-07-07 DE DE60318948T patent/DE60318948T2/de not_active Expired - Fee Related
- 2003-07-07 CN CNA2006101435561A patent/CN1974574A/zh active Pending
- 2003-07-07 DK DK03762957T patent/DK1521757T3/da active
- 2003-07-07 US US10/520,699 patent/US7449475B2/en not_active Expired - Fee Related
- 2003-07-07 UA UA20041210166A patent/UA77809C2/uk unknown
- 2003-07-07 NZ NZ537259A patent/NZ537259A/en unknown
- 2003-07-07 JP JP2004519472A patent/JP2005537255A/ja active Pending
- 2003-07-07 AU AU2003243122A patent/AU2003243122B2/en not_active Ceased
- 2003-07-07 PT PT03762957T patent/PT1521757E/pt unknown
- 2003-07-07 PL PL03374877A patent/PL374877A1/xx not_active Application Discontinuation
- 2003-07-07 CN CNB038191466A patent/CN1326858C/zh not_active Expired - Fee Related
- 2003-07-08 AR AR20030102463A patent/AR040475A1/es not_active Application Discontinuation
-
2005
- 2005-01-03 ZA ZA200500024A patent/ZA200500024B/xx unknown
- 2005-01-24 IS IS7662A patent/IS7662A/is unknown
- 2005-02-04 NO NO20050635A patent/NO20050635L/no not_active Application Discontinuation
- 2005-08-09 HK HK05106846A patent/HK1074622A1/xx not_active IP Right Cessation
-
2008
- 2008-04-03 CY CY20081100375T patent/CY1107915T1/el unknown
- 2008-11-05 US US12/265,251 patent/US20090062322A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US7449475B2 (en) | 2008-11-11 |
AU2003243122B2 (en) | 2006-09-28 |
BR0312560A (pt) | 2005-05-10 |
RU2320664C2 (ru) | 2008-03-27 |
EP1521757B1 (en) | 2008-01-30 |
CN1326858C (zh) | 2007-07-18 |
DK1521757T3 (da) | 2008-05-05 |
CA2492122A1 (en) | 2004-01-15 |
DE60318948T2 (de) | 2009-05-20 |
AU2003243122A1 (en) | 2004-01-23 |
ATE385235T1 (de) | 2008-02-15 |
DE60318948D1 (de) | 2008-03-20 |
ZA200500024B (en) | 2006-02-22 |
US20090062322A1 (en) | 2009-03-05 |
JP2005537255A (ja) | 2005-12-08 |
CN1974574A (zh) | 2007-06-06 |
RU2004137278A (ru) | 2005-09-10 |
WO2004005295A1 (en) | 2004-01-15 |
TW200413386A (en) | 2004-08-01 |
HK1074622A1 (en) | 2005-11-18 |
CY1107915T1 (el) | 2013-09-04 |
CN1675218A (zh) | 2005-09-28 |
EP1521757A1 (en) | 2005-04-13 |
AR040475A1 (es) | 2005-04-06 |
ES2298575T3 (es) | 2008-05-16 |
NO20050635L (no) | 2005-03-31 |
NZ537259A (en) | 2006-08-31 |
IS7662A (is) | 2005-01-24 |
PT1521757E (pt) | 2008-04-03 |
PL374877A1 (en) | 2005-11-14 |
MXPA05000278A (es) | 2005-03-31 |
US20050245741A1 (en) | 2005-11-03 |
UA77809C2 (en) | 2007-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE0202133D0 (sv) | Novel compounds | |
SE0302811D0 (sv) | Novel compounds | |
ATE433447T1 (de) | Pyrimiidinverbindungen | |
SE0301700D0 (sv) | Novel compounds | |
SE0104140D0 (sv) | Novel Compounds | |
MXPA02012425A (es) | Compuestos nuevos. | |
SE0200920D0 (sv) | Novel compounds | |
TW200801003A (en) | Novel compounds | |
TW200738658A (en) | Novel compounds | |
SE0202539D0 (sv) | Compounds | |
ATE332301T1 (de) | Antivirale pyrazolopyridin verbindungen | |
SE0303541D0 (sv) | New compounds | |
NO20062900L (no) | Nye forbindelser | |
TW200740781A (en) | Novel compounds | |
SE0302139D0 (sv) | Novel compounds | |
SE0401762D0 (sv) | Novel compounds | |
NO20050088L (no) | Kationisk substituerte difenylazefidinoner, fremgangsmate for deres fremstilling, medikamenter inneholdende nevnte forbindelser og anvendelse derav | |
TW200833670A (en) | Novel compounds 569 | |
SE0300480D0 (sv) | Novel compounds | |
SE0403171D0 (sv) | New compounds | |
SE0400850D0 (sv) | Novel Compounds | |
TW200512201A (en) | New heterocyclic amides | |
TW200730512A (en) | Novel compounds | |
SE0101038D0 (sv) | Novel compounds | |
SE0300092D0 (sv) | Novel compounds |